Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
about
Animal models for Ebola and Marburg virus infectionsCurrent ebola vaccinesMouse models for filovirus infectionsEbola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusA vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virusInduction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse.Potential vaccines and post-exposure treatments for filovirus infections.CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouseProtective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.The application of virus-like particles as vaccines and biological vehicles.Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.Chicken IgY Fc Linked to Bordetella avium ompA and Taishan Pinus massoniana Pollen Polysaccharide Adjuvant Enhances Macrophage Function and Specific Immune Responses.High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test.Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex.Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.
P2860
Q21131118-3D027EB0-DFE4-47FE-950D-4F4B0A56EBC2Q21534720-48FC6599-9673-4454-AEAE-14D1A589975EQ27011569-060E4CA9-8CFA-430D-AA71-25B0894AB116Q30234637-053B9298-3EE3-4E30-9374-1115DD293F70Q30235073-52A288E2-123D-4CC3-94B9-55ED0E9E5D05Q33572691-054A0637-F0BD-4D73-A464-96B6AEE9E880Q34463780-B6013FC9-F0D3-4170-8507-EBC3B1778795Q34540207-A71DD4D3-BB89-4112-A46E-965F7AC65725Q35598223-99C57F9F-FB3A-44A7-A2AC-F7D07A1BB12DQ35772032-C23EAC65-4273-4C1E-92CA-243345E0AE4DQ36130780-12DC6623-C672-4CBF-B8AF-7A6C979582CFQ36404178-1643D912-CA67-4628-896A-DFB922270899Q37683742-006A5E7D-863E-4694-8DF9-AAC6A70532C7Q37976671-94CEF15A-D562-469A-86F4-697031ED129FQ38603912-8768FA99-3306-437B-9821-604C229DA51CQ38799374-0667975F-3D0F-4C5D-984C-F90DCEB5FB97Q40052567-DAAFE1F4-18A7-4746-B250-E28F42317700Q40076985-240B4FC1-1FBC-42C1-8940-E27F7BDC50CFQ40327185-D4582E39-74D5-44EE-B469-EAB0C4FA92CFQ41355686-111F2097-DFB9-449A-A2DB-968839F8B127Q41631517-F32F5EF7-7CCA-418B-85D9-5A875945BC3DQ47550612-8C32EF2C-AC62-4C76-ADE3-4495F39521B9Q51347966-48DEF126-16FA-4926-BD77-7AF94FD9B342Q51730564-E6B756E6-EE4F-4448-8858-70B346C9C5B1Q54939538-0B916AA5-CF21-484F-9B8C-B11510350AECQ55010162-8B67D0FC-9B93-400C-B645-167BF285ACBA
P2860
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@ast
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@en
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@nl
type
label
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@ast
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@en
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@nl
prefLabel
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@ast
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@en
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@nl
P2093
P2860
P921
P1433
P1476
Ebola virus glycoprotein Fc fu ...... challenge in vaccinated mice.
@en
P2093
Gerardo G Kaplan
Jerome Jacques
Krishnamurthy Konduru
Mohanraj Manangeeswaran
Siham Nakamura
Steven B Bradfute
Steven C Wood
Sufi Morshed
P2860
P304
P356
10.1016/J.VACCINE.2011.01.113
P407
P50
P577
2011-02-15T00:00:00Z